OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
Webinar on Verified Antigen
Verified Antigen Webinar

Browse all lysates


spacer
OriGene in recent publications
Quantitative analysis of human neonatal Fc receptor (FcRn) tissue expression in transgenic mice by online peptide immuno-affinity LC-HRMS Anal. Chem. Mar 2016 [FCGRT]

Interaction between Esophageal Squamous Cell Carcinoma and Adipose Tissue in Vitro Am. J. Pathol. Mar 2016 [RETN]

The G-quadruplex-forming aptamer AS1411 potently inhibits HIV-1 attachment to the host cell Int. J. Antimicrob. Agents Mar 2016 [NCL]

Role of PHLPP1 in inflammation response: Its loss contributes to gliomas development and progression Int. Immunopharmacol. Mar 2016 [PHLPP1]

View All Citations >>

spacer

120 Protein belong to pathway "glioma"

divider

  Page: 1 of 6 
Direct Download
spacer
SKUAccnSymbolDescriptionShipping
TP321051NM_005465AKT3Recombinant protein of human v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (AKT3), transcript variant 1In Stock
TP324750NM_181690AKT3Recombinant protein of human v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) (AKT3), transcript variant 2In Stock
TP301156NM_000075CDK4Recombinant protein of human cyclin-dependent kinase 4 (CDK4)In Stock
TP720874NM_000075CDK4Purified recombinant protein of Human cyclin-dependent kinase 4 (CDK4)5 days
TP327978NM_001145306CDK6Purified recombinant protein of Homo sapiens cyclin-dependent kinase 6 (CDK6)In Stock
TP308560NM_001259CDK6Recombinant protein of human cyclin-dependent kinase 6 (CDK6)In Stock
TP720567NM_000389CDKN1ARecombinant protein of human cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A), transcript variant 15 Days
TP301765NM_078467CDKN1ARecombinant protein of human cyclin-dependent kinase inhibitor 1A (p21, Cip1) (CDKN1A), transcript variant 2In Stock
TP320937NM_000077CDKN2ARecombinant protein of human cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 1In Stock
TP723347NM_000077CDKN2APurified recombinant protein of Human cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 1.5 Days
TP723348NM_000077CDKN2APurified recombinant protein of Human cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) (CDKN2A), transcript variant 1.5 Days
TP308247NM_005225E2F1Recombinant protein of human E2F transcription factor 1 (E2F1)In Stock
TP760363NM_001949E2F3Purified recombinant protein of Human E2F transcription factor 3 (E2F3), full length, with N-terminal HIS tag, expressed in E.Coli, 50ugIn Stock
TP310817NM_001963EGFRecombinant protein of human epidermal growth factor (beta-urogastrone) (EGF)In Stock
TP720580NM_001963EGFPurified recombinant protein of Human epidermal growth factor (EGF), transcript variant 15 days
TP723068NM_001963EGFPurified recombinant protein of Human epidermal growth factor (EGF), transcript variant 1.5 Days
TP723821NM_001963EGFPurified recombinant protein of Human epidermal growth factor (EGF), transcript variant 15 days
TP700043NM_005228EGFRRecombinant protein of human epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian) (EGFR),residues 25-645 aa, expressed in human cellsIn Stock
TP700065NM_005228EGFRPurified protein of Homo sapiens epidermal growth factor receptor (EGFR), transcript variant 1, mutant L858R, with C-terminal MYC/DDK tag, expressed in human cells, 20ugIn Stock
TP700080NM_005228EGFRPurified protein of Homo sapiens epidermal growth factor receptor (EGFR), transcript variant 1, mutant K745_K750del, with C-terminal MYC/DDK tag, expressed in human cells, 20ugIn Stock

 

pattern
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title